Alnylam vets raise $193M to solve gene therapy’s biggest hurdle – delivery Therapeutics Aera Therapeutics emerged from stealth mode Thursday with a platform based on the work of Feng Zhang, Ph.D. and ex-Alnylam executive Akin Akinc at the helm. Read more February 16, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2023/02/Akin-Akinc.jpeg 350 465 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-02-16 11:12:092023-02-16 11:12:09Alnylam vets raise $193M to solve gene therapy's biggest hurdle - delivery
